Professor Mary Ryan, Vice Provost of Research and Enterprise, and Professor Dame Molly Stevens of Imperial College London, unveiled a prestigious Purple Plaque commemorating the remarkable achievements of Dr. Bakul Gupta and Deliver Biosciences at Imperial College London.

The Purple Plaque unveiling ceremony honours the pioneering work of Dr Gupta and Deliver Biosciences, the first UK biotech company spearheading the development of scalable and affordable curative therapies for patients in need. Leveraging a ground-breaking nanoparticle-based platform technology, Deliver Biosciences is revolutionising the treatment landscape by genetically modifying cells within patients to deliver transformative cures.

Dr. Gupta, the CEO and Co-founder of Deliver Biosciences, has been instrumental in driving the company’s vision since its inception in 2019, alongside her colleague, Dr. George Tetley. A distinguished alumna of UNSW Australia, Dr. Gupta holds a PhD and BSc in Nanotechnology and Chemistry. Following her postdoctoral training at Imperial College London under the guidance of Prof. Dame Molly Stevens, she embarked on her entrepreneurial journey with Deliver Biosciences.

Dr. Gupta has received numerous accolades, including being listed among the Top 30 Biotech Entrepreneurs to Watch and receiving prestigious accolades such as Innovate UK’s Women In Innovation award. Her contributions have left an indelible mark on the UK entrepreneurial ecosystem, inspiring future generations of innovators.

The Purple Plaque, awarded by Innovate UK, part of UK Research and Innovation, signifies the significant impact of Dr. Gupta and Deliver Biosciences in advancing scientific innovation and improving patient care. Innovate UK is dedicated to fostering a vibrant innovation ecosystem that supports businesses in developing life-changing technologies.

For more information on the ceremony, please visit: https://www.imperial.ac.uk/news/253536/imperial-alumnus-dr-bakul-gupta-receives/